| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.089 | 0.08 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.08 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |